摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-CBS

中文名称
——
中文别名
——
英文名称
(R)-CBS
英文别名
(3aR)-3,3-diphenyl-3a,4,5,6-tetrahydro-1H-pyrrolo[1,2-c][1,3,2]oxazaborole
(R)-CBS化学式
CAS
——
化学式
C17H18BNO
mdl
——
分子量
263.147
InChiKey
NSAZIMJIRLGSEG-MRXNPFEDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.69
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    12.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-甲基环戊烯(R)-CBSbis(cyclohexanyl)borane 作用下, 以 1,2-二氯乙烷 为溶剂, 反应 4.0h, 生成 trans-(2-Methylcyclopentyl)boronate
    参考文献:
    名称:
    反式-2-取代环烷基三氟硼酸钾的合成方法
    摘要:
    本发明公开了反式‑2‑取代环己基三氟硼酸钾的合成方法,属于有机合成领域。从环酮出发与格氏试剂或锂试剂加成随后脱水得到取代烯烃,随后与邻苯二酚硼烷或脯胺醇硼烷加成反应后,氟氢化钾直接淬灭处理后得到反式‑2‑取代环己基三氟硼酸钾,采用邻苯二酚硼烷得到消旋体产品,手性脯胺醇硼烷得到对映纯产品。该方法成本低廉,原料来源方便,操作简单,具有工业化放大的前景。
    公开号:
    CN109503639B
  • 作为产物:
    参考文献:
    名称:
    使用聚合物负载的 Corey-Bakshi-Shibata 催化剂高效合成 (R)-去氧肾上腺素
    摘要:
    报道了使用 Corey-Bakshi-Shibata (CBS) 催化剂制备 (R)-去氧肾上腺素盐酸盐的有效且温和的合成路线。为避免均相反应的催化剂回收过程冗长,制备了聚合物负载的CBS催化剂,并初步尝试在实验室规模上实现连续还原,有助于(R)-去氧肾上腺素的合成以具有成本效益的方式。
    DOI:
    10.1246/cl.170028
  • 作为试剂:
    描述:
    (E)-1-(tert-butyldimethylsilyl)-3-phenylprop-2-en-1-one(R)-CBSdimethyl sulfide borane 作用下, 以 四氢呋喃 为溶剂, 反应 2.25h, 以79%的产率得到(E)-1-(tert-butyldimethylsilyl)-3-phenylprop-2-en-1-ol
    参考文献:
    名称:
    Stereoselective anti-SN2′ Mitsunobu reaction of α-hydroxy-α-alkenylsilanes
    摘要:
    A novel silyl group-directed anti-S(N)2' reaction of allylic alcohols under Mitsunobu reaction conditions is described. The Mitsunobu reaction of alpha-hydroxy-alpha-alkenylsilanes with a TBS or TIPS group gave the anti-S(N)2' product, in which regio- and stereochemical outcomes of the reaction depended on the steric bulkiness of the silyl group. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2010.11.080
点击查看最新优质反应信息

文献信息

  • Ethanolamine derivatives having sympathomimetic and anti-pollakiuria
    申请人:Fujisawa Pharmaceutical Co., Ltd.
    公开号:US05387710A1
    公开(公告)日:1995-02-07
    This invention relates to new ethanolamine derivatives having gut selective sympathomimetic and anti-pollakiuria activities and represented by the general formula [I]: ##STR1## wherein R.sup.1 is aryl or a heterocyclic group, each of which may be substituted with halogen, etc., R.sup.2 is hydrogen, halogen, nitro, hydroxy, lower alkyl optionally substituted with acyl, lower alkenyl optionally substituted with acyl, lower alkoxy optionally substituted with acyl, or amino optionally substituted with acyl(lower)alkyl, R.sup.3 is hydrogen, an N-protective group, or lower alkyl optionally substituted with lower alkylthio, n is an integer of 0 to 3, and a heavy solid line means a single bond or a double bond, provided that when n is 1, then 1) R.sup.1 is a condensed aromatic hydrocarbon group or a heterocyclic group, each of which may be substituted with halogen, etc., and the like, and pharmaceutically acceptable salts thereof to processes for the preparation thereof and to a pharmaceutical composition comprising the same.
    这项发明涉及具有肠道选择性交感兴奋作用和抗多尿活性的新乙醇胺衍生物,其通式为[I]:其中R.sup.1是芳基或杂环基,每个都可以用卤素等取代,R.sup.2是氢、卤素、硝基、羟基、可选择用酰基取代的较低烷基、可选择用酰基取代的较低烯基、可选择用酰基取代的较低烷氧基、或者可选择用酰基(较低)烷基取代的氨基,R.sup.3是氢、N-保护基,或者可选择用较低烷基硫代取代的较低烷基,n是0到3的整数,重实线表示单键或双键,但当n为1时,则1)R.sup.1是缩合芳香烃基或杂环基,每个都可以用卤素等取代,等等,以及其药学上可接受的盐,以及制备它们的方法和包含相同的药物组合。
  • A Highly Effective Ruthenium System for the Catalyzed Dehydrogenative Cyclization of Amine-Boranes to Cyclic Boranes under Mild Conditions
    作者:Christopher J. Wallis、Gilles Alcaraz、Alban S. Petit、Amalia I. Poblador-Bahamonde、Eric Clot、Christian Bijani、Laure Vendier、Sylviane Sabo-Etienne
    DOI:10.1002/chem.201501569
    日期:2015.9.7
    disclosed a new ruthenium‐catalyzed dehydrogenative cyclization process (CDC) of diamine–monoboranes leading to cyclic diaminoboranes. In the present study, the CDC reaction has been successfully extended to a larger number of diamine–monoboranes (4–7) and to one amine–borane alcohol precursor (8). The corresponding NB(H)N‐ and NB(H)O‐containing cyclic diaminoboranes (12–15) and oxazaborolidine (16) were
    我们最近披露了一种新的钌催化的二胺-单硼烷烷的脱氢环化过程(CDC),可形成环状的二氨基硼烷。在本研究中,CDC反应已经成功地扩展到二胺- monoboranes(更大数目的4 - 7)和一种胺-硼烷醇前体(8)。相应的NB(H)N-和NB(H)O含环状diaminoboranes(12 - 15)和恶唑硼烷(16)以高到高的产量获得。评估了起始胺-硼烷底物上的多种取代方式,并且还使用手性底物进行了反应。已经花了很多努力来了解钌CDC流程的机制。除了计算方法外,还对六碳链二胺一硼烷21进行了能够对导致NB(H)N键形成的催化过程的连续事件进行动力学区分的策略,并用15 N NMR研究。具有反应性NHMe末端的长寿命双-σ-硼烷钌中间体23进行了原位表征,并被证明可催化1的脱氢环化,确定双σ-硼烷钌配合物是CDC过程中的关键中间体。
  • Asymmetric synthesis of new chiral long chain alcohols
    作者:Tülay Yıldız、Ayşe Yusufoğlu
    DOI:10.1016/j.tetasy.2010.12.010
    日期:2010.12
    Sixteen new chiral alcohols with alkyl (C-11-C-19) and aryl, substituted aryl, hetero aryl and biaryl groups 2a-2t were synthesized by three different asymmetric reduction methods from their corresponding ketones 1a-1t. Chiral NaBH4 (method A), chiral BH3 (method B) and chiral AIP (method C) were used as asymmetric reduction catalysts. Chiral NaBH4 was modified by four different ligands 3a-3d, chiral BH3 and chiral AIP by four different ligands 4a-4d. Ligand 4c was synthesized for the first time in this work. Chiral NaBH4 generated chiral alcohols of (R)-configuration and chiral BH3 and chiral AIP of (S)-configuration with high enantiomeric excesses, were analysed by chiral HPLC. In order to determine the ee values by chiral HPLC, sixteen corresponding racemic alcohols, synthesized by reducing their corresponding ketones via NaBH4, were used for chiral resolution on a Daicel OD HPLC column. The sixteen starting ketones were synthesized in this study by Friedel-Craft acylation. The new chiral alcohols were characterized by IR, NMR, (H-1 and C-13), MS, elemental analyses and specific rotation. The reduction methods A, B and C were applied to these ketones for the first time in this study and were compared with each other. The relationship between the structure of the ketone and the yield and the enantiomeric excess was discussed. (C) 2010 Elsevier Ltd. All rights reserved.
  • Is It Possible To Estimate the Enantioselectivity of a Chiral Catalyst from Its Racemic Mixture?
    作者:Franz Lagasse、Masaki Tsukamoto、Christopher J. Welch、Henri B. Kagan
    DOI:10.1021/ja0300315
    日期:2003.6.1
    The evaluation of a racemic catalyst was investigated in the case of oxazaborolidine (OAB)-catalyzed borane reduction of 1,5-diphenyl-1,5-pentanedione, giving the corresponding diol. On the basis of the diastereoselectivity of the diols, it is possible to estimate the enantioselectivity (ee) of the first step, which correlates well with the ee in the reaction of the structurally similar phenyl n-pentyl ketone with enantiopure OAB catalyst. The measure of diastereoselectivity could be a tool for screening racemic catalysts without the need for resolving the individual enantiomers, if in the second step of the process there is no substrate control and no catalyst scrambling.
  • 反式-2-取代环烷基三氟硼酸钾的合成方法
    申请人:沧州普瑞东方科技有限公司
    公开号:CN109503639B
    公开(公告)日:2021-04-16
    本发明公开了反式‑2‑取代环己基三氟硼酸钾的合成方法,属于有机合成领域。从环酮出发与格氏试剂或锂试剂加成随后脱水得到取代烯烃,随后与邻苯二酚硼烷或脯胺醇硼烷加成反应后,氟氢化钾直接淬灭处理后得到反式‑2‑取代环己基三氟硼酸钾,采用邻苯二酚硼烷得到消旋体产品,手性脯胺醇硼烷得到对映纯产品。该方法成本低廉,原料来源方便,操作简单,具有工业化放大的前景。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐